Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Retinoate measurement (procedure) |
Component |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Retinoate ester measurement |
Component |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tretinoin adverse reaction |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin overdose |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental tretinoin overdose |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional tretinoin overdose (disorder) |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de trétinoïne d'intention indéterminée |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin [cytostatic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin 100 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin 500 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin 250 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin 250 microgram/g cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
embryopathie causée par l'acide rétinoïque |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin 0.05% liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin 1 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin 1 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mequinol 20 mg/mL and tretinoin 100 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing mequinol and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin + Tretinoin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tretinoin 400 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fluocinolone acetonide and hydroquinone and tretinoin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to tretinoin (finding) |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin- and tretinoin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clindamycin 1.2%/tretinoin 0.025% topical gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isotretinoin (substance) |
Is a |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Retinoic acid - acute promyelocytic leukemia syndrome (disorder) |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tretinoin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tretinoin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Retinoic acid syndrome |
Causative agent (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to tretinoin (finding) |
Causative agent (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 10 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 10 mg oral capsule |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 100 microgram/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 100 microgram/g cutaneous gel |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 500 microgram/g cutaneous cream |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 500 microgram/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 250 microgram/g cutaneous gel |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 250 microgram/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 250 microgram/g cutaneous lotion |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 250 microgram/g cutaneous lotion |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has basis of strength substance (attribute) |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has precise active ingredient |
False |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fluocinolone and hydroquinone and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing erythromycin and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clindamycin and tretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only erythromycin and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluocinolone and hydroquinone and tretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only mequinol and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tretinoin 400 microgram/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 400 microgram/g cutaneous gel |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 1 mg/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 1 mg/mL cutaneous cream |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 1 mg/g cutaneous gel |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 1 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tretinoin 500 microgram/mL cutaneous solution |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tretinoin 500 microgram/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mequinol 20 mg/mL and tretinoin 100 microgram/mL cutaneous solution |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mequinol 20 mg/mL and tretinoin 100 microgram/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mequinol and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluocinolone and hydroquinone and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin- and tretinoin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing fluocinolone and hydroquinone and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing mequinol and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clindamycin (as clindamycin phosphate) 10 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has precise active ingredient |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clindamycin (as clindamycin phosphate) 10 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Retinoate ester measurement |
Component |
True |
Tretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |